<DOC>
	<DOCNO>NCT01776320</DOCNO>
	<brief_summary>A Phase 4 clinical trial open , blind subject randomization treatment . Patients erectile problem give approve drug Vitaros treat condition . They give form questionnaires complete . The information collect used ass effectiveness , safety satisfaction level drug .</brief_summary>
	<brief_title>Efficacy , Safety Satisfaction VITAROS ( Transdermal Topical Alprostadil ) Men With Erectile Dysfunction</brief_title>
	<detailed_description>Transdermal topical alprostadil approve use Canada treatment erectile dysfunction . However , form treatment new , Canada first country world approve use . There publish article literature evaluate clinical acceptance . By perform Phase 4 , Open-Label , Non-Randomized , Clinical Trial Evaluate Efficacy , Safety Satisfaction VITAROS ( transdermal topical alprostadil ) Men Erectile Dysfunction , study improve understand method treatment compare conventional treatment .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Alprostadil</mesh_term>
	<criteria>18y r old Has mildtomoderate erectile dysfunction Currently previous treat erectile dysfunction use PDE5 inhibitor , vacuum erection device ( VED ) , intracavernosal injection ( ICI ) medical urethral system erection ( MUSE ) . Sexually active Has regular sexual partner Known allergy alprostadil Unable provide inform consent Unable understand complete questionnaire English Unable return posttreatment clinic evaluation Regular sexual partner unable understand complete questionnaire English Sexual partner pregnant lactating female</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Erectile Dysfunction</keyword>
	<keyword>Topical Alprostadil</keyword>
</DOC>